Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |